The Importance of Cytogenomics in the Diagnostic Pathway
Cytogenomics is the study of genetics that evaluates chromosomes and their relation to diseases. Through a combined analysis of chromosomes and molecular tests, clinicians can better understand and treat disease states. This complex, but necessary, part of the diagnostic pathway is critical because Cytogenomics has a direct impact on diagnosis.1
How does diagnosis of results occur?
Changes in chromosomes number or structure helps us to diagnose disease states, such as cancer and congenital disorders. Cytogenomics explores 2 aspects of human DNA to guide a diagnostic process: chromosome evaluation and molecular testing, such as Fluorescence In-Situ hybridization (FISH). Chromosomes are a “macro” look at the 23 paired compliments of human DNA.
Normal female karyotype
After specimen processing in the laboratory occurs, chromosomes can be arranged and analyzed by size, centromere location and banding pattern into an image called a karyotype. Chromosome analysis of metaphase spreads and karyotyping provides a more global overview or “map of the territory” to help navigate the diagnostic process.
HER2/CE17FFPET FISH
Molecular testing by FISH is a “micro” look at highly specific DNA sequences or genes. By attaching a fluorescently labelled probe, or tag, to the targeted area on the chromosome of interest, it can be visualized under a fluorescent microscope. FISH testing provides the specific “street address” or location on the chromosome map that defines with great specificity clinical information to assist in generating a diagnosis.
How are results determined? The Cytogenomics diagnostic pathway
Chromosome analysis
Cytogenomic analysis can be ordered from a variety of cell sources, including peripheral blood lymphocytes, bone marrow, ascites, skin, and solid tumors. Each of these specimen types are grown, or cultured, in different ways in the Cytogenomics laboratory to obtain metaphase spreads for chromosome analysis and/or FISH. Cultured cells are processed and “fixed” with a 1:1 methanol:acetic acid solution, then dropped onto glass slides under consistent humidity to allow the chromosomes to spread for visualization. The glass slides with the chromosome spreads are then colored with a contrasting stain and visualized under a light microscope. Some solid tumors are not cultured and are embedded in a wax paraffin block. Those blocks are then cut into thin sections and placed on a positively charged glass slide and used specifically for FISH assays. Chromosome analysis is performed by a highly trained technologist and assisted with a digital imaging system using highly intuitive chromosomal software. Utilization of digital solutions increase efficiencies and can be easily integrated with high speed slide scanning systems and automated analysis software platforms to speed the time to result to treating clinicians.
FISH analysis
Fluorescence In-Situ Hybridization, or FISH, assays can be done on several types of specimens, cultured chromosomes slides, as described above, or Formalin Fixed Paraffin Embedded Tissue (FFPET). Chromosome FISH is performed on cells captured in metaphase or interphase cycles of division. Metaphase cells will have dividing chromosomes on which we can visualize fluorescent probes. Interphase FISH will not offer mitotic cells, but probes can still be visualized for diagnostic analysis. FISH is analyzed on a florescent microscope with a digital imaging system, like chromosomes.
FFPET FISH is more complex in preparation and in analysis. Some solid tumors are not cultured and are embedded in a wax paraffin block. Those blocks are then cut into thin sections and placed on a positively charged glass slide and used specifically for FISH assays. FFPET slides must be deparaffinized, pretreated, denatured, and hybridized for FISH probes to be applied and analyzed. This historically has been a time-consuming, highly manual process with great variation in techniques and results. Automation has had a great impact on this area of FISH diagnostics, offering both fully-automated and semi-automated paraffin FISH processing. These automated solutions have greatly improved quality and efficiencies of performing FFPET FISH assays by decreasing the variability of temperatures, timing of solution changes, and manual handling.
Cytogenomic diagnostics- why is it important?
Chromosomes and FISH results work together to inform the clinical team that the team makes complex diagnostic treatment determinations. The insight Cytogenomic analysis yields powerful and clinically significant documentation of chromosomal states that could indicate disease and clarify management pathways. Cytogenomics has the duty to skillfully examine, analyze, and summarize data to expedite the diagnostic pathway.
About the presenter
April Schrank‐Hacker, Ed.D., Life Science Marketing Leader at Leica Biosystems, is a clinical laboratory specialist in Cytogenetics having over 30 years of experience in technology, research, innovation, and laboratory management. April earned her BS in Clinical Laboratory Sciences with a specialization in Cytogenetics from Thomas Jefferson University and is certified in cytogenetics through ASCP with the designation CG(ASCP) CM. Her Master’s degree was earned from the University of Pennsylvania in Organizational Dynamics (MSOD) with dual certifications in Organizational Development and Change Studies and Organizational Leadership. April earned her Doctoral degree in Organizational Leadership, where she was a Distinguished Research Fellowship scholar for her work on building high-performing leadership and teams in domains of chaos and complexity. She has coauthored over 30 peer-reviewed publications and posters.
Referenzen
1Pergament, E, Glob. libr. women med., (ISSN: 1756-2228) 2008; DOI 10.3843/GLOWM.1034 https://www.glowm.com/section_view/heading/Cytogenetics/item/341
Die Inhalte des Knowledge Pathway von Leica Biosystems unterliegen den Nutzungsbedingungen der Website von Leica Biosystems, die hier eingesehen werden können: Rechtlicher Hinweis. Der Inhalt, einschließlich der Webinare, Schulungspräsentationen und ähnlicher Materialien, soll allgemeine Informationen zu bestimmten Themen liefern, die für medizinische Fachkräfte von Interesse sind. Er soll explizit nicht der medizinischen, behördlichen oder rechtlichen Beratung dienen und kann diese auch nicht ersetzen. Die Ansichten und Meinungen, die in Inhalten Dritter zum Ausdruck gebracht werden, spiegeln die persönlichen Auffassungen der Sprecher/Autoren wider und decken sich nicht notwendigerweise mit denen von Leica Biosystems, seinen Mitarbeitern oder Vertretern. Jegliche in den Inhalten enthaltene Links, die auf Quellen oder Inhalte Dritter verweisen, werden lediglich aus Gründen Ihrer Annehmlichkeit zur Verfügung gestellt.
Vor dem Gebrauch sollten die Produktinformationen, Beilagen und Bedienungsanleitungen der jeweiligen Medikamente und Geräte konsultiert werden.
Copyright © 2024 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.